insulin glargine biosimilar
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for insulin glargine biosimilar, covering 2024-10-03 to 2024-10-03. Get the full timeline:
Most recent: Clinical Trial Update: Introducing Biosimilar Insulin Glargine to the Treatment Regimen of Children and Youth with Type 1 Diabetes in Mali [Phase 4]